Related Experiment Video
Updated: Jun 11, 2026
10:58
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
17.0K
Exploring the Interaction of RBD with Human β Defensin Type 2 Point Mutants: Insights from Molecular Dynamics
1Chemical Engineering Department, University of Rhode Island, Kingston, Rhode Island 02881, United States.
The Journal of Physical Chemistry. B
|February 10, 2025
Summary
Researchers investigated mutations in human beta defensin type 2 (hBD-2) to improve its binding with SARS-CoV-2 Spike-RBD. Some hBD-2 mutants showed enhanced binding, offering potential for new antiviral drug design against COVID-19.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- The SARS-CoV-2 pandemic necessitates novel therapeutic strategies.
- Natural antimicrobial peptides like human beta defensin type 2 (hBD-2) show potential against viruses.
- hBD-2 can inhibit SARS-CoV-2 entry by binding to the Spike-RBD and blocking ACE2 interaction.
Purpose of the Study:
- To investigate the impact of point mutations in hBD-2 on its binding affinity with the SARS-CoV-2 Receptor Binding Domain (RBD).
- To identify specific hBD-2 mutants with enhanced binding to RBD for potential therapeutic development.
Main Methods:
- Computational modeling was used to generate 247 hBD-2 point mutants within the RES18-30 binding region.
- All-atom molecular dynamics simulations were performed to analyze the binding dynamics between RBD and hBD-2 mutants.
- Binding free energy calculations (MM/PBSA), root-mean-square deviation (RMSD), and hydrogen bond analysis were conducted.
Main Results:
- Most hBD-2 point mutants exhibited weaker binding to RBD compared to the wild-type hBD-2.
- A select group of mutants, including C20I, C20K, R22W, R23H, R23L, Y24L, K25F, K25H, G28Y, T29R, and C30K, demonstrated significantly enhanced binding to RBD.
- These enhanced binding mutants suggest improved inhibition of viral entry.
Conclusions:
- Specific point mutations can enhance the binding affinity of hBD-2 to the SARS-CoV-2 RBD.
- These findings provide a foundation for designing novel hBD-2-based therapeutics for long-term SARS-CoV-2 treatment.
Related Concept Videos
01:49Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...